IL4 and Alzheimer disease: In AD, aberrant JAK/STAT pathway activation contributes to the overproduction of proinflammatory cytokines such as IL-4, IL-13, and IL-31, which are directly linked to barrier dysfunction, itch, and inflammation [14].